BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 38515112)

  • 1. AURKB promotes colorectal cancer progression by triggering the phosphorylation of histone H3 at serine 10 to activate CCNE1 expression.
    Li L; Xie K; Xie H; Wang L; Li Z; Lu Q; Feng J
    Aging (Albany NY); 2024 May; 16(9):8019-8030. PubMed ID: 38713155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squalene epoxidase promotes breast cancer progression by regulating CCNB1 protein stability.
    Tuluhong D; Gao H; Li X; Wang L; Zhu Y; Xu C; Wang J; Li H; Li Q; Wang S
    Exp Cell Res; 2023 Dec; 433(1):113805. PubMed ID: 37839786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel LINC02321 promotes cell proliferation and decreases cisplatin sensitivity in bladder cancer by regulating RUVBL2.
    Lu C; Gao H; Li H; Luo N; Fan S; Li X; Deng R; He D; Zhao H
    Transl Oncol; 2024 Jul; 45():101962. PubMed ID: 38677015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CircPKN2 promotes ferroptosis in bladder cancer by promoting the ubiquitination of Stearoyl-CoA Desaturase 1.
    Liu C; Zou Z; Lu S; Jin K; Shen Y; Huang T; Li W; Zhou G
    Cancer Gene Ther; 2024 May; ():. PubMed ID: 38802550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer.
    Borah NA; Reddy MM
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33915740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AURKB promotes bladder cancer progression by deregulating the p53 DNA damage response pathway via MAD2L2.
    Li L; Jiang P; Hu W; Zou F; Li M; Rao T; Ruan Y; Yu W; Ning J; Cheng F
    J Transl Med; 2024 Mar; 22(1):295. PubMed ID: 38515112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA PVT1 contributes to invasion and doxorubicin resistance of bladder cancer cells through promoting MDM2 expression and AURKB-mediated p53 ubiquitination.
    Jiang X; Li H; Fang Y; Xu C
    Environ Toxicol; 2022 Jun; 37(6):1495-1508. PubMed ID: 35213076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIX3, a tumor suppressor, inhibits astrocytoma tumorigenesis by transcriptional repression of AURKA/B.
    Yu Z; Sun Y; She X; Wang Z; Chen S; Deng Z; Zhang Y; Liu Q; Liu Q; Zhao C; Li P; Liu C; Feng J; Fu H; Li G; Wu M
    J Hematol Oncol; 2017 Jun; 10(1):115. PubMed ID: 28595628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA-binding protein RNPC1 acts as an oncogene in gastric cancer by stabilizing aurora kinase B mRNA.
    Ji CM; Zhang X; Fang W; Meng L; Wei X; Lu C
    Exp Cell Res; 2021 Sep; 406(1):112741. PubMed ID: 34302858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The promoting effect and mechanism of MAD2L2 on stemness maintenance and malignant progression in glioma.
    Liu Z; Wang S; Yu K; Chen K; Zhao L; Zhang J; Dai K; Zhao P
    J Transl Med; 2023 Nov; 21(1):863. PubMed ID: 38017538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting mutant p53 for cancer therapy: direct and indirect strategies.
    Hu J; Cao J; Topatana W; Juengpanich S; Li S; Zhang B; Shen J; Cai L; Cai X; Chen M
    J Hematol Oncol; 2021 Sep; 14(1):157. PubMed ID: 34583722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives.
    Venugopala KN; Chandrashekharappa S; Tratrat C; Deb PK; Nagdeve RD; Nayak SK; Morsy MA; Borah P; Mahomoodally FM; Mailavaram RP; Attimarad M; Aldhubiab BE; Sreeharsha N; Nair AB; Alwassil OI; Haroun M; Mohanlall V; Shinu P; Venugopala R; Kandeel M; Nandeshwarappa BP; Ibrahim YF
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34200764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitotic syndicates Aurora Kinase B (AURKB) and mitotic arrest deficient 2 like 2 (MAD2L2) in cohorts of DNA damage response (DDR) and tumorigenesis.
    Marima R; Hull R; Penny C; Dlamini Z
    Mutat Res Rev Mutat Res; 2021; 787():108376. PubMed ID: 34083040
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.